Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Localisation With an Ultra-low Dose of Superparamagnetic Iron Oxide Nanoparticles in Patients With Breast Cancer

NCT06169072 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06169072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06169072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Localisation With an Ultra-low Dose of Superparamagnetic Iron Oxide Nanoparticles in Patients With Breast Cancer
Lead sponsor
Vastra Gotaland Region
Phase
Phase 2
Overall status
Recruiting
Start date
January 1, 2023
Completion date
July 1, 2027
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, sentinel lymph node